These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 14724567)

  • 41. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
    Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
    Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
    Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
    Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
    Yuan-Jing F; Nan-Shan H; Lian X
    Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
    Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
    Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein.
    Lin SH; Nishino M; Luo W; Aumais JP; Galfione M; Kuang J; Yu-Lee LY
    Oncogene; 2004 Apr; 23(14):2499-506. PubMed ID: 14676831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.
    Xing N; Qian J; Bostwick D; Bergstralh E; Young CY
    Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Rahman KM; Banerjee S; Ali S; Ahmad A; Wang Z; Kong D; Sakr WA
    Cancer Res; 2009 May; 69(10):4468-75. PubMed ID: 19435906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
    Wall NR; O'Connor DS; Plescia J; Pommier Y; Altieri DC
    Cancer Res; 2003 Jan; 63(1):230-5. PubMed ID: 12517802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells.
    Yang CT; Li JM; Weng HH; Li YC; Chen HC; Chen MF
    Cancer Gene Ther; 2010 Feb; 17(2):120-30. PubMed ID: 19730451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.
    Asechi H; Hatano E; Nitta T; Tada M; Iwaisako K; Tamaki N; Nagata H; Narita M; Yanagida A; Ikai I; Uemoto S
    Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Silencing of survivin gene enhances chemosensitivity of human tongue cancer cell line Tca8113 to cisplatin].
    Xu JH; Pan CB; Huang HZ; Zhang B; Wang JG; Zhang LT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):280-3. PubMed ID: 17686279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of blocking androgen receptor expression with specific hammerhead ribozyme on in vitro growth of prostate cancer cell line.
    Tong Q; Zhao J; Chen Z; Zeng F; Lu G
    Chin Med J (Engl); 2003 Oct; 116(10):1515-8. PubMed ID: 14570613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biological implications of the inhibition of survivin by RNA interference in human androgen-independent prostate carcinoma with highly metastatic potential].
    Zhu X; Ning JY; You JF; Wang JL; Cui XL; Fang WG; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):549-54. PubMed ID: 17134550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of apoptosis proteins in prostate cancer cell lines.
    McEleny KR; Watson RW; Coffey RN; O'Neill AJ; Fitzpatrick JM
    Prostate; 2002 May; 51(2):133-40. PubMed ID: 11948968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents.
    Dorai T; Goluboff ET; Olsson CA; Buttyan R
    Anticancer Res; 1997; 17(5A):3307-12. PubMed ID: 9413164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
    Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
    Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.
    Beger C; Pierce LN; Kruger M; Marcusson EG; Robbins JM; Welcsh P; Welch PJ; Welte K; King MC; Barber JR; Wong-Staal F
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):130-5. PubMed ID: 11136250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector.
    Gibson SA; Pellenz C; Hutchison RE; Davey FR; Shillitoe EJ
    Clin Cancer Res; 2000 Jan; 6(1):213-22. PubMed ID: 10656452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.